Giuseppe Curigliano

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Giuseppe Curigliano
Oct 30, 2024, 10:02 | Insight
Paper Alert ! Use of Antibody–Drug Conjugates in the Early Setting of Breast Cancer
Use of Antibody–Drug Conjugates in the Early Setting of Breast Cancer Authors: Chrysanthi Koukoutzeli, Dario…
Oct 29, 2024, 13:05 | Insight
Paolo Tarantino: My 100th scientific publication
Paolo Tarantino, Fellow at Dana-Farber Cancer Institute, shared a post on X: "It turns out…
Oct 25, 2024, 11:41 | Blog
Raffaele Colombo: Honored to discuss ADCs at the ENASymp24
Raffaele Colombo shared a post by Sandra Misale, Assistant professor at Sidney Kimmel Comprehensive Cancer…
Oct 22, 2024, 14:33 | Blog
Sebastian Szmit: Risk stratification and long-term follow-up proposed by ESC guidelines on cardiooncology
Sebastian Szmit shared a post by Monika Majewska, Editor, journalist, conference moderator at Pulse of…
Oct 18, 2024, 12:10 | Blog
From One-Size-Fits-All to Personalized Treatment: An article by Marleen Kok et al.
Maryam Lustberg shared on LinkedIn: "From One-Size-Fits-All to Personalized Treatment: Challenges and Potential Solutions. Opportunities…
Oct 13, 2024, 17:58 | Blog
Raffaele Colombo: Excited to be presenting ADCs at the 36th ENA symposium
The 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics will be held in person…
Oct 10, 2024, 16:44 | Blog
Giuseppe Curigliano: With T-DXd for HR-Positive Metastatic Breast Cancer
Giuseppe Curigliano shared an article on X: "DESTINY-Breast06 Shows Significant PFS Improvement With T-DXd for HR-Positive…
Oct 9, 2024, 16:03 | OncoDaily Pulse
Inside OncoDaily Party Barcelona
On September 13, 2024, OncoDaily Party took place at the Chiringuito Mokai Beach Bar in Barcelona, Spain.…
Oct 7, 2024, 16:33 | Blog
Lika Katselashvili: Developing combination therapies with biologics in TNBC
Lika Katselashvili shared on X: "Incredibly grateful for the amazing experience at IEO Milano under…
Oct 6, 2024, 17:29 | Blog
Lizzy Smyth: Privileged to co-chair the first ESMO ADC Advanced Course with Giuseppe Curigliano
Lizzy Smyth shared a post on X by Alberto Puccini, adding: "What a privilege to…
Oct 5, 2024, 09:20 | Insight
DESTINY-Breast06 is the first study to investigate a HER2-directed therapy in patients with HER2-ultralow tumors - ASCO
ASCO shared a post on X: "Experts Giuseppe Curigliano & Aditya Bardia discuss the results of…
Oct 2, 2024, 15:37 | Blog
Zainab Shinkafi-Bagudu: Chairing Nigeria's Cancer Network to Address Survivors' Needs
Zainab Shinkafi-Bagudu shared a post on Linkedin: ''I take my role as Chair of the…
Sep 23, 2024, 11:36 | Blog
OncoDaily Party Barcelona
On September 13, 2024, OncoDaily Party took place at the Chiringuito Mokai Beach Bar in…
Sep 20, 2024, 23:18 | Blog
Yüksel Ürun: Key goals post ESMO24
Yüksel Ürun shared a post on LinkedIn: "Key goals post ESMO24 1.Integrate findings into practice…
Sep 19, 2024, 11:07 | Blog
Elias Ortega Chahla: ESMO - YO Mentorship Session
Elias Ortega Chahla, Medical Director (Hematology/Oncology), IQVIA, shared a post on LinkedIn: "ESMO - YO…
Sep 19, 2024, 09:29 | Insight
Guilherme Nader Marta: DESTINY-Breast06 trial out in The New England Journal of Medicine
Guilherme Nader Marta, Advanced Clinical Fellow - Dana-Farber Cancer Institute, shared a post on LinkedIn: "DESTINY-Breast06…
Sep 19, 2024, 09:19 | Blog
Taha Koray Sahin: Inspiring and valuable mentorship session at ESMO24
Taha Koray Sahin shared a post on X: "Big thanks to Giuseppe Curigliano for the insightful…
Sep 18, 2024, 12:21 | Blog
Andrea Botticelli: Presenting the Rome trial results at ESMO 24 Presidential Session
Andrea Botticelli posted on LinkedIn: "What a great emotion to present the Rome trial results at…
Sep 18, 2024, 09:18 | Insight
34 Posts Not to Miss From ESMO24 Day 4
The ESMO Congress 2024 took place in Barcelona, from September 13 to 17, 2024, at…
Sep 18, 2024, 00:08 | Insight
Paolo Tarantino: Testing T-DXd vs chemo for endocrine-refractory HR+ MBC
Paolo Tarantino shared a post on X: "Previously presented at ASCO24 by Giuseppe Curigliano, the impressive…
Sep 1, 2024, 15:03 | Blog
ESMO is seeking a new Editor-in-Chief to ESMO Open
ESMO - European Society for Medical Oncology shared a post on LinkedIn: "ESMO is seeking…
Aug 31, 2024, 16:51 | Insight
Vivek Subbiah: Future framework for Tissue agnostic drug development
Vivek Subbiah shared a post on LinkedIn: "Hot off the press, Presenting to the world a…
Aug 26, 2024, 20:01 | Blog
EU HTA Cooperation on ECO Community 365 Roundtable series
European Cancer Organisation (ECO) shared a post on LinkedIn: “A landmark piece of EU legislation…
Aug 22, 2024, 03:05 | Insight
Jarushka Naidoo: Excited to be a part of the Swiss Oncology Summer School
Jarushka Naidoo shared on LinkedIn: “Excited to be a part of the Swiss Oncology Summer…
Aug 18, 2024, 13:43 | Insight
ECO Community 365 Roundtable: EU HTA Regulation
European Cancer Organisation shared on LinkedIn: “A landmark piece of EU legislation to achieve greater…
Aug 18, 2024, 07:29 | Blog,Opinion
Paolo Tarantino: Do all patients with TNBC need 5 neoadjuvant drugs + 1 year of IO?
Paolo Tarantino shared a post on X about recent paper by Marleen Kok et al., titled…
Aug 10, 2024, 05:56 | Blog
Natacha Bolaños and Giuseppe Curigliano discuss EU legislation on HTA - ECO
European Cancer Organisation (ECO) shared on LinkedIn: "Are we ready for Joint Clinical Assessments? On…
Aug 5, 2024, 01:55 | Societies
Scientific Committees at the ESMO Congress 2024
The ESMO Congress is a globally influential oncology platform that brings together clinicians, researchers, patient…
Jul 31, 2024, 03:46 | Blog
ECO Community 365 Roundtable: HTA Regulation
European Cancer Organisation posted on LinkedIn: "A landmark piece of European Union legislation to achieve…
Jul 30, 2024, 12:17 | Blog
María Natalia Gandur Quiroga: Highlights from the article 'Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals'
María Natalia Gandur Quiroga posted on LinkedIn about recent paper by Irma Bisceglia et al., titled…
Jul 27, 2024, 22:17 | Insight
Commentary led by Marleen Kok highlights all questions in early TNBC post-KN522
Erika Hamilton shared on X: "This commentary led by Marleen Kok highlights all the pertinent…
Jul 26, 2024, 00:03 | Blog
Elisa Agostinetto: Must-read by Marleen Kok on the limitations of KEYNOTE-522
Elisa Agostinetto shared on X: "Out in JCO a must-read by Marleen Kok on the…
Jul 25, 2024, 11:55 | Blog
European School of Oncology - The 2023 ESMO guidelines for early breast cancer diagnosis, treatment, and follow-up
European School of Oncology shared on LinkedIn: "Stay up-to-date with our e-Session 'The 2023 ESMO guidelines…
Jul 25, 2024, 08:58 | Insight
Marleen Kok: How do we get from one-size-fits-all to personalized treatment for TNBC
Marleen Kok, Breast Medical Oncologist at the Netherlands Cancer Institute, shared on X: "Today from…
Jul 25, 2024, 03:18 | Insight
6th and 7th ABC international consensus guidelines for the management of advanced breast cancer
ABC Global Alliance shared on LinkedIn: “Inequalities in access to care are a major hurdle…
Jul 24, 2024, 07:30 | Blog
European Union legislation on Health Technology Assessment - European Cancer Organisation
European Cancer Organisation shared a post on LinkedIn: ''A landmark piece of European Union legislation…
Jul 21, 2024, 10:33 | Blog
Filippo Montemurro: RWE of drug-drug interactions on abemaciclib
Filippo Montemurro, Senior Medical Director at F. Hoffmann La Roche, shared a post on X: "Clinical…
Jul 16, 2024, 05:54 | Blog
Unprecedented level of scientific discourse at INNOVATE
Hussein Tawbi, Professor at The University of Texas MD Anderson Cancer Center, shared a post…
Jul 15, 2024, 21:23 | Blog
Liz Burton: Humbling opportunity to co-chair the first International Neoadjuvant Immunotherapy Across Cancers in Naples
Liz Burton, Executive Director at UT MD Anderson Cancer Center, shared a post on X: …
Jul 15, 2024, 04:50 | Insight
Paolo Tarantino: Our article on ADCs is among the top 10 most cited in CA Cancer Journal
Paolo Tarantino, shared a post on LinkedIn about a recent paper titled "Antibody–drug conjugates: Smart…
Jul 6, 2024, 04:44 | Insight
The first meeting of our new Research Policy Network - ECO
European Cancer Organisation (ECO) shared on LinkedIn:  “The first meeting of our new Research Policy…
Jul 3, 2024, 13:35 | OncoDaily Pulse
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
OncoDaily at the Annual ASCO Conference 2024: A Comprehensive Report The American Society of Clinical…
Jul 3, 2024, 10:44 | Blog
Abeid M. Athman Omar: The last four months have been very eventful for me
Abeid M. Athman Omar, Clinical Oncology Specialist at Kenyatta University, shared a post on LinkedIn: "The last…
Jun 30, 2024, 10:58 | Insight
Eleonora Nicolò: Our analysis on safety and efficacy of new drugs investigated in phase I/II clinical trials by age
Eleonora Nicolò, Research Fellow at Weill Cornell Medicine, shared a post on X: "Just out…
Jun 25, 2024, 07:12 | Blog
Elisa Agostinetto and Giuseppe Curigliano discuss the results of Destiny-Breast06
Elisa Agostinetto shared on LinkedIn: "At ASCO24 I met Prof Giuseppe Curigliano to discuss the results…
Jun 22, 2024, 02:02 | Blog
Sameh Abdelmalak: Dr. Giuseppe Curigliano discussing ASCO24 DESTINY-Breast06
Sameh Abdelmalak, Director, Oncology, Educational Partnerships at VuMedi, made the following post on X: "Check out…
Jun 20, 2024, 16:05 | Insight
Eliz Tazimova: Our project at ESMO In Focus Breast Cancer 2024 Bulgaria
Eliz Tazimova, COO at Institute for Research of Breast Cancer Treatment, shared a post on…
Jun 19, 2024, 01:47 | Blog
ESO Congratulate Barbara Jereczek-Fossa and Giuseppe Curigliano On Being Elected Presidents of ESTRO and ESMO
European School of Oncology (ESO) shared a post on LinkedIn:      . “The European School of…
Jun 15, 2024, 16:02 | Dialogues
Oncodaily Talks: Dialogue with Giuseppe Curigliano, hosted by Chandler Park
OncoDaily Talks gathers people worldwide to discuss challenges in cancer care. We share creative solutions…
Jun 15, 2024, 02:42 | Blog
Hesham El Ghazaly: Congrats Giuseppe Curigliano , joining as ESMO President-Elect 2025-2026
Giuseppe Curigliano shared a post by Hesham El Ghazaly, Professor of clinical Oncology at Ain Shams University,…
Jun 12, 2024, 15:37 | Societies
Giuseppe Curigliano has been appointed as the President Elect of ESMO
The European Society for Medical Oncology (ESMO) has announced the results of its presidential election.…
Jun 12, 2024, 09:57 | Blog
Giuseppe Curigliano will be the ESMO President 2027-2028
ESMO shared a post on LinkedIn: "ESMO is pleased to share the ESMO Presidential Election election…
Jun 10, 2024, 10:08 | Societies
Vivek Subbiah: I endorse Dr. Giuseppe Curigliano for ESMO President 2027-28
Vivek Subbiah shared on X: "The elections for the ESMO President 2027-2028 are happening, its…
Jun 10, 2024, 10:01 | Blog
Alessandra Curioni Fontecedro: Giuseppe Curigliano represents ESMO for me
Alessandra Curioni Fontecedro, Head of Medical Oncology at HFR Fribourg – Cantonal Hospital, shared Antonio…
Jun 10, 2024, 05:58 | Blog
Paolo Tarantino: Feeling very lucky to be part of this international network of young oncologists
Paolo Tarantino shared a post on X: “Feeling very lucky to be part of this international…
Jun 9, 2024, 15:55 | Insight
Chandler Park: Giuseppe Curigliano on sequencing 1st line and beyond Stage IV ER+ breast cancer
Chandler Park recently shared on LinkedIn: “How to sequence treatments for 1st line and beyond…
Jun 9, 2024, 12:29 | Societies
Giuseppe Curigliano: Enhancing the careers of young oncologists is the best way to shape the future of global oncology
Giuseppe Curigliano shared a post by ESMO on X, adding: "'A society grows great when older…
Jun 9, 2024, 09:02 | Blog
Rossana Berardi: Thanks Giuseppe Curigliano for helping us to reach a wider audience
Rossana Berardi, Professor in Medical Oncology at Marche Polytechnic University, shared a post by Giuseppe Curigliano, Professor…
Jun 9, 2024, 08:58 | Societies
Chandler Park: Dr. Curigliano is a dedicated compassionate leader with a track record for mentorship and medical education
Chandler Park  recently shared on X: "As a near-decade member of ESMO, I always look…
Jun 9, 2024, 08:12 | Blog
Gevorg Tamamyan: The Yvonne Award received a warm welcome from the international professional community
Gevorg Tamamyan shared on LinkedIn: "Last Friday, on May 31, the OncoDaily Party and Yvonne Awards Ceremony…
Jun 9, 2024, 04:15 | Blog
Paolo Marchetti: Take a few minutes to vote for Prof. Giuseppe Curigliano as ESMO President
Paolo Marchetti, Professor of Medical Oncology at Sapienza University of Rome, shared a post on X:…
Jun 8, 2024, 03:53 | Societies
25 Posts From ASCO24 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting was held from May 31st…
Jun 7, 2024, 11:07 | Blog
Paolo Tarantino: Grateful to be part of the ESMO Open team
Paolo Tarantino shared a post by Giuseppe Curigliano on LinkedIn: "Grateful to be part of the…
Jun 7, 2024, 06:42 | Blog
Khalid El Bairi: I am officially supporting Prof Giuseppe Curigliano for ESMO Presidential Election
Khalid El Bairi shared a post on X: "I am officially supporting Prof Giuseppe Curigliano for…
Jun 7, 2024, 01:18 | Insight
Giuseppe Curigliano: Congratulations to Myriam Chalabi on her outstanding paper
Giuseppe Curigliano shared a post by NEJM on X: "Congratulations to Myriam Chalabi on her outstanding…
Jun 6, 2024, 12:28 | Blog
Giuseppe Curigliano: What an incredible experience at ASCO2024
Giuseppe Curigliano shared a post on their LinkedIn: ''What an incredible experience at ASCO2024! Thrilled…
Jun 5, 2024, 15:33 | Insight
Giuseppe Curigliano: Excited that the DESTINY-06 trial was presented at ASCO2024
Giuseppe Curigliano shared on LinkedIn: “Excited to share that the DESTINY-06 trial was presented at…
Jun 5, 2024, 15:22 | Insight
Piotr Wysocki: T-DXd in metastatic ER+/HER2-low breast cancer patients after endocrine treatment failure
Piotr Wysocki recently posted on LinkedIn: "Results of a Destiny-Breast06 trial have been presented by…
Jun 5, 2024, 06:27 | Blog
Giuseppe Curigliano: Proud to serve on the Educational Committee for ASCO2024
Giuseppe Curigliano shared on LinkedIn:            . "Proud to serve on…
Jun 5, 2024, 05:51 | Blog
Francisco J. Esteva: Congratulations to Giuseppe Curigliano for the presentation of the DESTINY-Breast06 trial at ASCO24
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
Jun 5, 2024, 04:25 | Blog
Giuseppe Curigliano: Excited to see NBC News highlight the groundbreaking results of DESTINY-06
Giuseppe Curigliano reposted Erika Hamilton's post on LinkedIn, adding:    . "Excited to see NBC…
Jun 5, 2024, 02:37 | Blog
Giuseppe Curigliano: Lillian Siu continues to inspire and drive advancements in oncology
Giuseppe Curigliano shared on LinkedIn: "Congratulations to Lillian Siu, the recipient of the ASCO24 Karnofsky Award!…
Jun 4, 2024, 12:39 | Blog
Giuseppe Curigliano: Together, we can achieve more!
Giuseppe Curigliano shared on LinkedIn:      . "Investing in the next generation of oncologists…
Jun 3, 2024, 15:25 | Societies
15 Posts From ASCO24 Day 3 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
Jun 2, 2024, 10:34 | Blog
Barbara Jereczek-Fossa: Proud to endorse Giuseppe Curigliano for the ESMO presidential election
Barbara Jereczek-Fossa, Full Professor of Radiation Oncology at Milan University, shared a post on LinkedIn:…
Jun 2, 2024, 09:05 | Blog
Giuseppe Curigliano: Celebrating Gender Equity and Inclusion with Dr. Don S. Dizon at ASCO24
Giuseppe Curigliano shared on LinkedIn: "Celebrating Gender Equity and Inclusion with the inspiring Dr. Don…
Jun 1, 2024, 06:27 | Blog
Giuseppe Curigliano: I've witnessed the profound impact of ESMO on nurturing the young generation of medical oncologists
Giuseppe Curigliano shared a post by ESMO on X/Twitter: "For 25 years, I've witnessed the profound…
May 31, 2024, 17:02 | Insight
Yakup Ergün: A guide where we can find answers to every question about aBC
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on…
May 31, 2024, 16:28 | Blog
Yelena Y. Janjigian: I am over the moon with how this Giants of Cancer Care event turned out
Yelena Y. Janjigian shared a post by Giuseppe Curigliano on X: "Another amazing ASCO memory! I am over…
May 30, 2024, 14:50 | Blog
Stefano Magno: Our endorsement to Giuseppe Curigliano for ESMO presidential election
Stefano Magno, Breast Surgeon at Agostino Gemelli University Policlinic, recently shared on X: "From the…
May 29, 2024, 23:08 | Blog
Antonio Marra: I strongly endorse Giuseppe Curigliano's vision as ESMO President
Antonio Marra, Medical Oncologist at the European Institute of Oncology, shared on LinkedIn: "Voting for ESMO…
May 28, 2024, 06:15 | Blog
Roberto Iacovelli: My preference for ESMO Presidency is for Giuseppe Curigliano
Roberto Iacovelli shared on X/Twitter: "The next days are so important for our Society, ESMO. New…
May 26, 2024, 06:54 | Positive
Yvonne Award Winners 2024 by OncoDaily
We are excited to announce the esteemed winners of the Yvonne Award 2024 by OncoDaily, designed…
May 25, 2024, 15:15 | Blog
Paolo Tarantino: I’m extremely excited to support Giuseppe Curigliano for the next ESMO Presidential Elections
Paolo Tarantino shared on LinkedIn: "I’m extremely excited to support Giuseppe Curigliano for the next ESMO…
May 25, 2024, 11:11 | Societies
Chiara Corti endorses Giuseppe Curigliano for the ESMO Presidental election
Chiara Corti, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: . "I…
May 25, 2024, 09:54 | Blog
Gevorg Tamamyan: The best candidate for ESMO Presidency is Giuseppe Curigliano
Gevorg Tamamyan shared on LinkedIn: "Wonderful person, a great physician-scientist and a dear friend Giuseppe…
May 25, 2024, 07:41 | Insight
Paolo Tarantino: I’m extremely excited to support Giuseppe Curigliano for the next ESMO Presidential Elections!
Paolo Tarantino shared on LinkedIn: “I’m extremely excited to support Giuseppe Curigliano for the next…
May 25, 2024, 01:55 | Blog
Myriam Chalabi: ESMO voting starts May 28th
Myriam Chalabi shared a post by ESMO on X/Twitter: "For those not eager on clicking to…
May 24, 2024, 00:42 | Societies
Vivek Subbiah wholeheartedly supports and endorses Dr. Giuseppe Curigliano for ESMO President 2027-28
Vivek Subbiah shared on X: "Exciting news! The elections for the ESMO President 2027-2028 are…
May 20, 2024, 11:18 | Drugs
Elisa Agostinetto: Our review on emerging treatments for HER2+ breast cancer
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared a post on LinkedIn: “Now…
May 15, 2024, 04:35 | Blog
Paolo Tarantino: A pleasure to co-host the latest ESMO Open podcast with Giuseppe Curigliano
Paolo Tarantino shared a post by ESMO - European Society for Medical Oncology on LinkedIn, adding:…
May 13, 2024, 12:54 | Blog
Become part of the conversation about the science presented at ESMO Breast24
European Society for Medical Oncology shared on their X page: "Do not miss the latest…
May 13, 2024, 07:12 | Blog
Paolo Tarantino: DESTINY-Breast06 will be presented on 6/2 at ASCO24 by my friend and mentor of many years Giuseppe Curigliano
Paolo Tarantino shared on X: "DESTINY-Breast06 will be presented on 6/2 at ASCO24 by my…
Apr 29, 2024, 20:00 | Opinion
Erika Hamilton: Really feel like we don't need to be testing for HER-2 for TDXd in breast cancer
Erika Hamilton shared a post by Giuseppe Curigliano, Chief of the Clinical Division of Early…
Apr 25, 2024, 19:25 | Blog
Khalid El Bairi interview with Dr Ouissam Al Jarroudi (MD)
Khalid El Bairi, International Executive Council at NCODA, shared on LinkedIn: "Dr Ouissam Al Jarroudi (MD)…
Apr 24, 2024, 10:38 | Insight
Khalid El Bairi: My interview with Ouissam Al Jarroudi, one of the leading experts in breast cancer in Morocco
Khalid El Bairi, Founder of The Cancer Biomarkers Working Group, shared on LinkedIn: “Ouissam Al…
Apr 23, 2024, 11:34 | Blog
Vivek Subbiah: What a beautiful venue for a terrific meeting - the Italian Summit of Precision Oncology
Vivek Subbiah shared a post on X: "American Academy of Rome! What a beautiful venue…
Apr 15, 2024, 14:38 | Insight
New Paper Alert! Refining Treatment Approaches in Early Breast Cancer Patients with Pathologic Complete Response
Refining Treatment Approaches in Early Breast Cancer Patients with Pathologic Complete Response Authors: Carmine Valenza,…
Mar 23, 2024, 15:20 | Blog
Giuseppe Curigliano: Grateful to Stella Kyriakides Commissioner for Health at European Commission for visiting European Institute of Oncology (IEO)
Giuseppe Curigliano, Chief of the Clinical Division of Early Drug Development at European Institute of…
Mar 22, 2024, 18:47 | Blog
Alessandra Fontecedro: The first Swiss Oncology Summer School
Alessandra Fontecedro, Head Medical Oncology at HFR Fribourg Hospital, shared on LinkedIn: "To medical students:…
12
All: 107 Posts: 1 - 100
Special Coverage